摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-chloro-5-methyl-3-[(2S,3S,4R,5R,6R)-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-yl]-1H-indole | 887338-74-1

中文名称
——
中文别名
——
英文名称
7-chloro-5-methyl-3-[(2S,3S,4R,5R,6R)-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-yl]-1H-indole
英文别名
——
7-chloro-5-methyl-3-[(2S,3S,4R,5R,6R)-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-yl]-1H-indole化学式
CAS
887338-74-1
化学式
C43H42ClNO5
mdl
——
分子量
688.263
InChiKey
WSZDMQPAJSTNOU-ZAIYSUOQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.2
  • 重原子数:
    50
  • 可旋转键数:
    14
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    61.9
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • 1-SUBSTITUTED-3-BETA-D-GLUCOPYRANOSYLATED NITROGENOUS HETERO-CYCLIC COMPOUNDS AND MEDICINES CONTAINING THE SAME
    申请人:Yonekubo Shigeru
    公开号:US20090074738A1
    公开(公告)日:2009-03-19
    A compound having an SGLT1 and/or SGLT2 inhibitory activity which is usable as an agent for the prevention or treatment of diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications, obesity, etc. It is a 1-substituted-3-(β-D-glycopyranosyl) nitrogen-containing heterocyclic compound represented by the general formula (I), a prodrug thereof, or a pharmaceutically acceptable salt thereof, or a hydrate or a solvate thereof; an SGLT inhibitor containing the same; a pharmaceutical composition containing the same and a combination pharmacy of them. In the formula, A represents an alkylene group or alkenylene group; B represents a single bond, —O—, —S— or —NH—; C represents an optionally substituted aryl or heteroaryl group; Q independently represents a carbon atom which a hydrogen atom or a substituent binds to, or a nitrogen atom.
    一种具有SGLT1和/或SGLT2抑制活性的化合物,可用作预防或治疗糖尿病、餐后高血糖、糖耐量受损、糖尿病并发症、肥胖等的药物。该化合物是一种1-取代-3-(β-D-葡萄糖苷基)氮杂环化合物,其通式表示为(I),其前药,或其药学上可接受的盐,或其水合物或溶剂化物;包含该化合物的SGLT抑制剂;包含该化合物的制药组合物和药物组合制剂。在该式中,A代表烷基或烯烃基;B代表单键,—O—,—S—或—NH—;C代表可选择取代的芳基或杂芳基;Q独立地表示氢原子或取代基结合的碳原子或氮原子。
  • US7750145B2
    申请人:——
    公开号:US7750145B2
    公开(公告)日:2010-07-06
  • Convenient synthesis of [3R-(3α,4β,5α,6β)]-2-[7-chloro-1-(4-ethylbenzyl)-5-methyl-1H-indol-3-yl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
    作者:Yong-Hai Liu、Da-Li Li、Qin-Hua Li、Jun-Fang Yang、Lu-De Lu
    DOI:10.1007/s00706-010-0350-0
    日期:2010.8
    A novel and convenient approach for the preparation of [3R-(3 alpha,4 beta,5 alpha,6 beta)]-2-[7-chloro-1-(4-ethylbenzyl)-5-methyl-1H-indol-3-yl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol is developed. It has been achieved in about 72% overall yield.
查看更多